Updated

Updated · Yahoo Finance · Aug 18

Peptide Synthesis Market to Reach $2.59 Billion by 2031 as Therapeutics Demand Lifts Growth

Updated

Updated · Yahoo Finance · Aug 18

Peptide Synthesis Market to Reach $2.59 Billion by 2031 as Therapeutics Demand Lifts Growth

1 articles · Updated · Yahoo Finance · Aug 18

$2.59 billion is Mordor Intelligence’s 2031 forecast for the peptide synthesis market, up from an estimated $1.90 billion in 2026 at a 6.39% CAGR.
Peptide-based drug development is driving that growth as pharmaceutical and biotech companies expand work in chronic disease, oncology, metabolic disorders and rare diseases.
Automation, high-throughput synthesizers, advanced purification and greener chemistry are improving efficiency, while AI-assisted peptide design and larger contract manufacturing capacity broaden commercial opportunities.
North America holds a significant market share, Europe remains a notable market, and Asia-Pacific is growing fastest as China, India, Japan and South Korea expand manufacturing and biotech investment.

Sources

Center100%

Will AI models that design peptides for specific biological effects completely render traditional trial-and-error synthesis obsolete by 2031?

Could toxic solvent regulations cripple the booming peptide drug market before AI and green chemistry can save it?

With obesity drugs driving unprecedented demand, are current market projections vastly underestimating an impending global manufacturing bottleneck?

1 total

Center100%